The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation
Open accessAbstract
The splicing-factor oncoprotein SRSF1 (also known as SF2/ASF or ASF/SF2) is upregulated in breast cancers. We investigated the ability of SRSF1 to transform human and mouse mammary epithelial cells in vivo and in vitro. SRSF1-overexpressing COMMA-1D cells formed tumors, following orthotopic transplantation to reconstitute the mammary gland. In three-dimensional (3D) culture, SRSF1-overexpressing MCF-10A cells formed larger acini than control cells, reflecting increased proliferation and delayed apoptosis during acinar morphogenesis. These effects required the first RNA-recognition motif and nuclear functions of SRSF1. SRSF1 overexpression promoted alternative splicing of BIM (also known as BCL2L11) and BIN1 to produce isoforms that lack pro-apoptotic functions and contribute to the phenotype. Finally, SRSF1 cooperated specifically with MYC to transform mammary epithelial cells, in part by potentiating eIF4E activation, and these cooperating oncogenes are significantly coexpressed in human breast tumors. Thus, SRSF1 can promote breast cancer, and SRSF1 itself or its downstream effectors may be valuable targets for the development of therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alternative isoform regulation in human tissue transcriptomes
Wang, E. T., Sandberg, R., Luo, S., Khrebtukova, I., Zhang, L., Mayr, C., Kingsmore, S. F., Schroth, G. P., & Burge, C. B. (2008) · Nature · doi:10.1038/nature07509 · Cited by 5,181
Listening to silence and understanding nonsense: exonic mutations that affect splicing
Cartegni, L., Chew, S. L., & Krainer, A. R. (2002) · Nature Reviews Genetics · doi:10.1038/nrg775 · Cited by 2,209
Self-citationDebnath, J., Muthuswamy, S. K., & Brugge, J. S. (2003) · Methods · doi:10.1016/s1046-2023(03)00032-x · Cited by 1,995
Self-citationBim: a novel member of the Bcl-2 family that promotes apoptosis
O'Connor, L. (1998) · The EMBO Journal · doi:10.1093/emboj/17.2.384 · Cited by 1,166
Modelling glandular epithelial cancers in three-dimensional cultures
Debnath, J., & Brugge, J. S. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1695 · Cited by 1,015
Dysregulation of the TSC-mTOR pathway in human disease
Inoki, K., Corradetti, M. N., & Guan, K.-L. (2005) · Nature Genetics · doi:10.1038/ng1494 · Cited by 972
Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap
Lazaris-Karatzas, A., Montine, K. S., & Sonenberg, N. (1990) · Nature · doi:10.1038/345544a0 · Cited by 956
Specific protection against breast cancers by cyclin D1 ablation
Yu, Q., Geng, Y., & Sicinski, P. (2001) · Nature · doi:10.1038/35082500 · Cited by 934
The gene encoding the splicing factor SF2/ASF is a proto-oncogene
Karni, R., de Stanchina, E., Lowe, S. W., Sinha, R., Mu, D., & Krainer, A. R. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1209 · Cited by 934
Self-citationDebnath, J., Mills, K. R., Collins, N. L., Reginato, M. J., Muthuswamy, S. K., & Brugge, J. S. (2002) · Cell · doi:10.1016/s0092-8674(02)01001-2 · Cited by 763
Self-citationRegulation of alternative pre-mRNA splicing by hnRNP A1 and splicing factor SF2
Mayeda, A., & Krainer, A. R. (1992) · Cell · doi:10.1016/0092-8674(92)90477-t · Cited by 735
Self-citationmTORC1-Mediated Cell Proliferation, But Not Cell Growth, Controlled by the 4E-BPs
Dowling, R. J. O., Topisirovic, I., Alain, T., Bidinosti, M., Fonseca, B. D., Petroulakis, E., Wang, X., Larsson, O., Selvaraj, A., Liu, Y., et al. (2010) · Science · doi:10.1126/science.1187532 · Cited by 726
Regulation of Alternative Splicing in Vivo by Overexpression of Antagonistic Splicing Factors
Cáceres, J. F., Stamm, S., Helfman, D. M., & Krainer, A. R. (1994) · Science · doi:10.1126/science.8085156 · Cited by 618
Self-citationRegulation of Apoptosis by Alternative Pre-mRNA Splicing
Schwerk, C., & Schulze-Osthoff, K. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.05.026 · Cited by 594
The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis
Ruggero, D., Montanaro, L., Ma, L., Xu, W., Londei, P., Cordon-Cardo, C., & Pandolfi, P. P. (2004) · Nature Medicine · doi:10.1038/nm1042 · Cited by 586
ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini
Muthuswamy, S. K., Li, D., Lelievre, S., Bissell, M. J., & Brugge, J. S. (2001) · Nature Cell Biology · doi:10.1038/ncb0901-785 · Cited by 554
Self-citationOncogenes and Tumor Suppressor Genes
Lee, E. Y. H. P., & Muller, W. J. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a003236 · Cited by 508
A specific subset of SR proteins shuttles continuously between the nucleus and the cytoplasm
Cáceres, J. F., Screaton, G. R., & Krainer, A. R. (1998) · Genes & Development · doi:10.1101/gad.12.1.55 · Cited by 493
Self-citationZhan, L., Rosenberg, A., Bergami, K. C., Yu, M., Xuan, Z., Jaffe, A. B., Allred, C., & Muthuswamy, S. K. (2008) · Cell · doi:10.1016/j.cell.2008.09.045 · Cited by 436
Self-citationSR splicing factors serve as adapter proteins for TAP-dependent mRNA export
Huang, Y., Gattoni, R., Stévenin, J., & Steitz, J. A. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00089-3 · Cited by 426
Cáceres, J. F., Misteli, T., Screaton, G. R., Spector, D. L., & Krainer, A. R. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.138.2.225 · Cited by 416
Self-citationA novel role for shuttling SR proteins in mRNA translation
Sanford, J. R., Gray, N. K., Beckmann, K., & Cáceres, J. F. (2004) · Genes & Development · doi:10.1101/gad.286404 · Cited by 407
Cell Motility Is Controlled by SF2/ASF through Alternative Splicing of the Ron Protooncogene
Ghigna, C., Giordano, S., Shen, H., Benvenuto, F., Castiglioni, F., Comoglio, P. M., Green, M. R., Riva, S., & Biamonti, G. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.10.026 · Cited by 389
BIN1 is a novel MYC–interacting protein with features of a tumour suppressor
Sakamuro, D., Elliott, K. J., Wechsler-Reya, R., & Prendergast, G. C. (1996) · Nature Genetics · doi:10.1038/ng0996-69 · Cited by 387
The connection between splicing and cancer
Srebrow, A., & Kornblihtt, A. R. (2006) · Journal of Cell Science · doi:10.1242/jcs.03053 · Cited by 335
An Alternative Splicing Network Links Cell-Cycle Control to Apoptosis
Moore, M. J., Wang, Q., Kennedy, C. J., & Silver, P. A. (2010) · Cell · doi:10.1016/j.cell.2010.07.019 · Cited by 316
The Splicing Factor SF2/ASF Regulates Translation Initiation by Enhancing Phosphorylation of 4E-BP1
Michlewski, G., Sanford, J. R., & Cáceres, J. F. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.03.013 · Cited by 277
Functional analysis of pre-mRNA splicing factor SF2/ASF structural domains.
Cáceres, J. F., & Krainer, A. R. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06160.x · Cited by 257
Self-citationTopisirovic, I., Ruiz-Gutierrez, M., & Borden, K. L. B. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2677 · Cited by 257
Involvement of SR Proteins in mRNA Surveillance
Zhang, Z., & Krainer, A. R. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.10.031 · Cited by 237
Self-citationOncogenic Splicing Factor SRSF1 Is a Critical Transcriptional Target of MYC
Das, S., Anczuków, O., Akerman, M., & Krainer, A. R. (2012) · Cell Reports · doi:10.1016/j.celrep.2011.12.001 · Cited by 202
Self-citationSF2/ASF autoregulation involves multiple layers of post-transcriptional and translational control
Sun, S., Zhang, Z., Sinha, R., Karni, R., & Krainer, A. R. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1750 · Cited by 201
Self-citationGe, K., DuHadaway, J., Du, W., Herlyn, M., Rodeck, U., & Prendergast, G. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.17.9689 · Cited by 195
A Splicing-Independent Function of SF2/ASF in MicroRNA Processing
Wu, H., Sun, S., Tu, K., Gao, Y., Xie, B., Krainer, A. R., & Zhu, J. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.02.021 · Cited by 191
Self-citationMao, D. Y. L., Watson, J. D., Yan, P. S., Barsyte-Lovejoy, D., Khosravi, F., Wong, W. W.-L., Farnham, P. J., Huang, T. H.-M., & Penn, L. Z. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00297-5 · Cited by 185
Functional domains of the human splicing factor ASF/SF2.
Zuo, P., & Manley, J. L. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06161.x · Cited by 184
c-Myc and eIF4F Are Components of a Feedforward Loop that Links Transcription and Translation
Lin, C.-J., Cencic, R., Mills, J. R., Robert, F., & Pelletier, J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5876 · Cited by 180
Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis
Stickeler, E., Kittrell, F., Medina, D., & Berget, S. M. (1999) · Oncogene · doi:10.1038/sj.onc.1202671 · Cited by 175
Nuclear Export and Retention Signals in the RS Domain of SR Proteins
Cazalla, D., Zhu, J., Manche, L., Huber, E., Krainer, A. R., & Cáceres, J. F. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.19.6871-6882.2002 · Cited by 169
Self-citationKey signalling nodes in mammary gland development and cancer: Myc
Hynes, N. E., & Stoelzle, T. (2009) · Breast Cancer Research · doi:10.1186/bcr2406 · Cited by 159
Bim Regulation of Lumen Formation in Cultured Mammary Epithelial Acini Is Targeted by Oncogenes
Reginato, M. J., Mills, K. R., Becker, E. B. E., Lynch, D. K., Bonni, A., Muthuswamy, S. K., & Brugge, J. S. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.11.4591-4601.2005 · Cited by 152
Self-citationLi, X., Wang, J., & Manley, J. L. (2005) · Genes & Development · doi:10.1101/gad.1359305 · Cited by 145
The 17q23 Amplicon and Breast Cancer
Sinclair, C. S., Rowley, M., Naderi, A., & Couch, F. J. (2003) · Breast Cancer Research and Treatment · doi:10.1023/a:1023081624133 · Cited by 136
Watermann, D. O., Tang, Y., Hausen, A. Z., Jäger, M., Stamm, S., & Stickeler, E. (2006) · Cancer Research · doi:10.1158/0008-5472.can-04-3294 · Cited by 136
Bin1 functionally interacts with Myc and inhibits cell proliferation via multiple mechanisms
Elliott, K., Sakamuro, D., Basu, A., Du, W., Wunner, W. H., Staller, P., Gaubatz, S., Zhang, H., Prochownik, E. V., Eilers, M., et al. (1999) · Oncogene · doi:10.1038/sj.onc.1202670 · Cited by 126
The splicing-factor oncoprotein SF2/ASF activates mTORC1
Karni, R., Hippo, Y., Lowe, S. W., & Krainer, A. R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801376105 · Cited by 125
Self-citationNgo, J. C. K., Giang, K., Chakrabarti, S., Ma, C.-T., Huynh, N., Hagopian, J. C., Dorrestein, P. C., Fu, X., Adams, J. A., & Ghosh, G. (2008) · Molecular Cell · doi:10.1016/j.molcel.2007.12.017 · Cited by 123
Li, S., Takasu, T., Perlman, D., Peterson, M. S., Burrichter, D., Avdulov, S. V., Bitterman, P. B., & Polunovsky, V. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208821200 · Cited by 115
Scheper, G. C., Parra-Palau, J. L., Wilson, M., van Kollenburg, B., Vertegaal, A. C. O., Han, Z., & Proud, C. G. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.16.5692-5705.2003 · Cited by 113
Expression of splicing factors in human ovarian cancer
Fischer, D., Noack, K., Runnebaum, I. B., Watermann, D. O., Kieback, D., Stamm, S., & Stickeler, E. (2004) · Oncology Reports · doi:10.3892/or.11.5.1085 · Cited by 106
He, X., Ee, P. L. R., Coon, J. S., & Beck, W. T. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0439 · Cited by 103
Deugnier, M., Faraldo, M. M., Teulière, J., Thiery, J. P., Medina, D., & Glukhova, M. A. (2006) · Developmental Biology · doi:10.1016/j.ydbio.2006.02.007 · Cited by 93
Structural and functional analysis of RNA and TAP binding to SF2/ASF
Tintaru, A., Hautbergue, G. M., Hounslow, A. M., Hung, M., Lian, L., Craven, C. J., & Wilson, S. A. (2007) · EMBO Reports · doi:10.1038/sj.embor.7401031 · Cited by 92
Mami, U., Miyashita, T., Shikama, Y., Tadokoro, K., & Yamada, M. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)03145-3 · Cited by 91
Ghigna, C., Moroni, M., Porta, C., Riva, S., & Biamonti, G. (1998) · PubMed · Cited by 80
Mechanisms of oncogenic cooperation in cancer initiation and metastasis.
Pedraza, L. G. (2006) · PubMed Central · Cited by 58
Spancake, K. M., Anderson, C. B., Weaver, V. M., Matsunami, N., Bissell, M. J., & White, R. L. (1999) · PubMed · Cited by 35
Deletion of the N-terminus of SF2/ASF Permits RS-Domain-Independent Pre-mRNA Splicing
Shaw, S. D., Chakrabarti, S., Ghosh, G., & Krainer, A. R. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000854 · Cited by 27
Self-citationMiao, J., Chen, G. G., Yun, J., Chun, S.-Y., Zheng, Z.-Z., Ho, R. L. K., Chak, E. C. W., Xia, N., & Lai, P. B. S. (2007) · APOPTOSIS · doi:10.1007/s10495-007-0093-5 · Cited by 24
Cited by
Alternative splicing: a pivotal step between eukaryotic transcription and translation
Kornblihtt, A. R., Schor, I. E., Alló, M., Dujardin, G., Petrillo, E., & Muñoz, M. J. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3525 · Cited by 853
RNA-Binding Proteins in Cancer: Old Players and New Actors
Pereira, B., Billaud, M., & Almeida, R. (2017) · Trends in Cancer · doi:10.1016/j.trecan.2017.05.003 · Cited by 773
RNA splicing factors as oncoproteins and tumour suppressors
Dvinge, H., Kim, E., Abdel-Wahab, O., & Bradley, R. K. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.51 · Cited by 687
Hallmarks of alternative splicing in cancer
Oltean, S., & Bates, D. O. (2014) · Oncogene · doi:10.1038/onc.2013.533 · Cited by 664
Differentiation of mammary tumors and reduction in metastasis upon Malat1 lncRNA loss
Arun, G., Diermeier, S., Akerman, M., Chang, K.-C., Wilkinson, J. E., Hearn, S., Kim, Y., MacLeod, A. R., Krainer, A. R., Norton, L., et al. (2016) · Genes & Development · doi:10.1101/gad.270959.115 · Cited by 585
Self-citation
Metadata
- Authors
- Anczuków, O., Rosenberg, A. Z., Akerman, M., Das, S., Zhan, L., Karni, R., Muthuswamy, S. K., & Krainer, A. R.
- Venue
- Nature Structural & Molecular Biology
- Published
- 2012-01-15
- Volume
- 19
- Issue
- 2
- Pages
- 220-228
- ISSN
- 1545-9985 (ISSN-L)
- 1545-9993
- OpenAlex
- W2000567082
- Cited by
- 447
- References
- 59
- FWCI
- 11.38
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.